Skip to main content
. 2020 Jan 21;11(3):216–236. doi: 10.18632/oncotarget.27400

Figure 2. Response to prexasertib treatment across a pan-cancer cell line panel.

Figure 2

The panel is composed of 572 well-characterized cancer cell lines representing 29 different adult and pediatric tumor types. Y-axis shows log of the mean of the absolute IC50 value from replicate measurements (see Supplementary Table 1); x-axis displays the cancer type, abbreviation, and corresponding number of cell lines tested.